A solution and solid state conformation of 2-diphenylphosphinoyl-1,3-dioxanes. The nature of O-C-P anomeric interactions.
摘要:
Diastereoisomeric 2-diphenylphosphinoyl-1,3-dioxanes 1-4 were synthesized either via the Arbuzov reaction of isopropyl diphenylphosphinite with (1,3-dioxan-2-yl)trimethylammonium iodides or via the transacetalization reaction between 1,3-diols and diphenyl(diethoxymethyl)phosphine oxide. The latter reaction afforded less thermodynamically stable isomers of 3 and 4 in a good yield (44 and 56%, respectively). The magnitude of the anomeric effect in this system determined according to the Franck's equation was found to be 19.7 kJ/mol. Both the NMR and X-ray structural data concerning cis-4,6-dimethyl-1, 3-dioxane derivatives 4 suggest that the anomeric effect could stem from several interactions, including the n(o)-sigma*c-p negative hyperconjugation and intramolecular hydrogen bond formation.
[EN] PROCESSES FOR PREPARING SUBSTITUTED N-ARYL-N'-[3-(1H-PYRAZOL-5-YL) PHENYL] UREAS AND INTERMEDIATES THEREOF<br/>[FR] METHODES DE PREPARATION DE N-ARYL-N'-[3-(1H-PYRAZOL-5-YL) PHENYLUREES] SUBSTITUEES ET LEURS INTERMEDIAIRES
申请人:ARENA PHARM INC
公开号:WO2005103011A1
公开(公告)日:2005-11-03
The present invention is directed to processes for the preparation of substituted phenylpyrazole ureas of Formula (I), that are useful as 5-HT2A serotonin receptor modulators for the treatment of disease.
Processes for Preparing Substituted N-Aryl-N'-[3-(1H-Pyrazol-5-Yl) Phenyl] Ureas and Intermediates Thereof
申请人:Fritch Robert John
公开号:US20070293685A1
公开(公告)日:2007-12-20
The present invention is directed to processes for the preparation of substituted phenylpyrazole ureas of Formula (I), that are useful as 5-HT
2A
serotonin receptor modulators for the treatment of disease.